INSL5 may be a unique marker of colorectal endocrine cells and neuroendocrine tumors
INSL5 may be a unique marker of colorectal endocrine cells and neuroendocrine tumors
复制标题
DOI:
10.1016/j.bbrc.2013.02.042
复制
发表时间:
2013-03-22
影响因子:
3.1
通讯作者:
Ohnishi, Hirohide
中科院分区:
文献类型:
--
作者:
Mashima, Hirosato;Ohno, Hideki;Ohnishi, Hirohide
Insulin-like peptide 5 (INSL5) is a member of the insulin superfamily, and is a potent agonist for RXFP4. We have shown that INSL5 is expressed in enteroendocrine cells (EECs) along the colorectum with a gradient increase toward the rectum. RXFP4 is ubiquitously expressed along the digestive tract. INSL5-positive EECs have little immunoreactivity to chromogranin A (CgA) and might be a unique marker of colorectal EECs. CgA-positive EECs were distributed normally along the colorectum in INSL5 null mice, suggesting that INSL5 is not required for the development of CgA-positive EECs. Exogenous INSL5 did not affect the proliferation of human colon cancer cell lines, and chemically-induced colitis in INSL5 null mice did not show any significant changes in inflammation or mucosa] healing compared to wild-type mice. In contrast, all of the rectal neuroendocrine tumors examined co-expressed INSL5 and RXFP4. INSL5 may be a unique marker of colorectal EECs, and INSL5 RXFP4 signaling might play a role in an autocrine/ paracrine fashion in the colorectal epithelium and rectal neuroendocrine tumors. (C) 2013 Elsevier Inc. All rights reserved.